●  Owner: Nanning Zhongheng Investment Co., Ltd

●  Construction site: Nanning Economic and Technological Development Zone

●  Capacity: at phase 1: 200 million bottles/year of thrombus cure (freeze-dried) for TCM injection, 500 million tablets/year of lithiasis cure tablets, 3.5 billion tablets/year of blood blockage cure tablets, 300 million capsules/year of thrombus cure capsules, 300 million capsules/year of Fuyanjing (gynecologic inflammation cure) capsules, and 700 million bottles/year of neutral borosilicate glass penicillin; at phase 2: 4.8 million bottles/year fluorescein sodium injection, 24 million bottles/year of Dianhydrodulcitol, and 100 million tablets/year "2 in 1" antihypertensive and lipid-lowering tablets; at phase 3: 36 million bottles/year of Cabozantide and 150000 bottles/year of recombinant double-gene adenovirus injections.

●  Project overview: The project site is located in Nanning Economic and Technological Development Zone. The total planned land area of the base is 614151.54 square meters (921.22 mu), and the land area is 569601.53 square meters (854.4 mu), including 350 mu for TCM production, 211.02 mu for research and development center, 120 mu for chemical drug, 68.85 mu for biological product, and 104.52 mu for packaging materials.